Literature DB >> 14437972

A clinical assessment of orphenadrine (disipal) in the treatment of Parkinsonism.

L R ROBINSON, T H DICK.   

Abstract

Entities:  

Keywords:  PARALYSIS AGITANS/therapy; PARASYMPATHOLYTICS/therapy

Mesh：

Substances：

Year:  1960        PMID： 14437972      PMCID： PMC2384361     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  5 in total

1.  [Psychiatric significance of a new anti-parkinsonian drug].

Authors: 
Journal:  Ann Med Psychol (Paris)       Date:  1959-01       Impact factor: 0.380

2.  Treatment of paralysis agitans with orphenadrine (disipal) hydrochloride; results in one hundred seventy-six cases.

Authors:  L J DOSHAY; K CONSTABLE
Journal:  J Am Med Assoc       Date:  1957-04-13

3.  Orphenadrine in the treatment of depression; a preliminary study.

Authors:  J B ROBITSCHER; S E PULVER
Journal:  Am J Psychiatry       Date:  1958-06       Impact factor: 18.112

4.  [Exploratory laparotomy in children with recurrent abdominal disease].

Authors:  C C W SMITH
Journal:  Ugeskr Laeger       Date:  1958-06-05

5.  The pharmacology of beta-dimethylaminoethyl-2-methylbenzhydrylether hydrochloride (BS 5930).

Authors:  U G BIJLSMA; A F HARMS; A B FUNCKE; H M TERSTEEGE; W T NAUTA
Journal:  Arch Int Pharmacodyn Ther       Date:  1956-05-01
  5 in total
  1 in total

1.  Assessment of drug therapy in Parkinsonism.

Authors:  G ONUAGULUCHI
Journal:  Br Med J       Date:  1963-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.